Permeation of hypericin in spheroids composed of different grade transitional cell carcinoma cell lines and normal human urothelial cells

J Urol. 2005 Jul;174(1):69-72. doi: 10.1097/01.ju.0000162037.49102.56.

Abstract

Purpose: We investigated the importance of E-cadherin expression on the selective accumulation of hypericin in superficial bladder cancer after intravesical instillation.

Materials and methods: Spheroids obtained from a panel of 3 transitional cell carcinoma cell lines, namely J-82, RT-4 (American Type Culture Collection, Manassas, Virginia) and RT-112 (German Collection of Micro-organisms and Cell Cultures, Braunschweig, Germany), and normal human urothelial (NHU) cells were incubated with hypericin. Accumulation was examined with fluorescence microscopy. Immunohistochemical staining was used to assess E-cadherin expression.

Results: Immunohistochemical staining showed E-cadherin expression in NHU (++), RT-112 (+) and RT-4 (+) spheroids, whereas E-cadherin expression was absent in J-82 spheroids. The highest intraspheroidal hypericin accumulation was observed in transitional cell carcinoma spheroids, whereas limited permeation was seen in NHU spheroids. Taken together the data point to an inverse relationship between E-cadherin expression and the permeation of hypericin throughout a 3-dimensional cellular matrix.

Conclusions: Loss of E-cadherin expression correlates with loss of intercellular adhesion, tight junction formation and enhanced paracellular transport. The data show that E-cadherin hampers the permeation of hypericin in spheroids and the loss of intercellular adhesion, present in superficial bladder cancer lesions, can be associated with enhanced hypericin permeation. Therefore, E-cadherin expression seems to have a pivotal role in the selective uptake of hypericin after intravesical instillation in human bladders.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anthracenes
  • Carcinoma, Transitional Cell / pathology*
  • Cell Line, Tumor
  • Humans
  • Perylene / analogs & derivatives*
  • Perylene / pharmacokinetics*
  • Radiation-Sensitizing Agents / pharmacokinetics*
  • Spheroids, Cellular / metabolism*
  • Tumor Cells, Cultured
  • Urinary Bladder Neoplasms / pathology*
  • Urothelium / cytology*

Substances

  • Anthracenes
  • Radiation-Sensitizing Agents
  • Perylene
  • hypericin